A nanoparticle's fate inside a cell is written into its design
Inside every living cell, a nanoparticle navigates an invisible architecture of proteins that will either guide it toward its purpose or dismantle it entirely. For decades, researchers designing nanomedicines could not truly see this journey — the tools available either blurred the picture or destroyed the very thing they sought to observe. Now, a team working across Hangzhou and Macau has developed a method using iron oxide nanoparticles that label their own protein neighbors in real time, without any genetic modification, offering science its clearest view yet of how a particle's surface design determines its fate inside a living cell.
- The core frustration in nanomedicine has been invisibility — researchers engineered particles with precision but lost sight of them the moment they crossed the cell membrane.
- Every existing tracking method carried a fatal compromise: microscopy was too blurry, proteomics required destroying the cell, and proximity labeling demanded genetic engineering that limited where it could be used.
- The new nanozyme approach dissolves that impasse by turning the nanoparticle itself into the labeling instrument, using its iron oxide chemistry to tag nearby proteins within sixty seconds in a living, unmodified cell.
- The results were unambiguous — mitochondria-targeted particles found their destination and recruited the right docking proteins, while untargeted particles were swept into lysosomes and destroyed, proving that surface design is cellular destiny.
- Because no genetic engineering is required, this method can now travel freely across cell types, tissues, and disease models, positioning it as a broadly applicable engine for accelerating rational nanomedicine design.
Inside a living cell, a nanoparticle is a traveler whose fate is decided by proteins it cannot choose. For years, this invisible negotiation was the central blind spot of nanomedicine — researchers could engineer particles with great care, but once those particles crossed the cell membrane, the picture went dark. Microscopy offered only blurred destinations. Proteomics required lysing the cell entirely, scrambling the very arrangement researchers needed to see. Proximity labeling could map protein interactions in their native state, but demanded genetic engineering, limiting its use across different biological systems.
A team led by Liu Yuan and Jing Ji at the Hangzhou Institute of Medicine, in collaboration with Dai Yunlu at the University of Macau, has now removed that constraint entirely. Their method — nanozyme proximity labeling — exploits the enzyme-like behavior of iron oxide nanoparticles themselves. When exposed to hydrogen peroxide, these particles act as chemical scissors, covalently tagging any proteins within immediate reach. The entire process takes about a minute, inside living cells, with no genetic modification required. The tagged proteins are then isolated and identified through mass spectrometry, producing a high-resolution map of the nanoparticle's protein neighborhood captured in the cell's natural state.
What that map revealed was decisive. Mitochondria-targeted nanoparticles showed a 1.5-fold enrichment of mitochondrial proteins nearby and had recruited trafficking proteins that anchored them to their intended destination. Untargeted particles, by contrast, were routed almost entirely to lysosomes — the cell's degradation machinery — where they would be broken down and eliminated. The difference was written entirely in surface chemistry.
Published in the Proceedings of the National Academy of Sciences, the work offers nanomedicine something it has long needed: a way to see the consequences of design choices in real time, across any cell type or tissue, without the barrier of genetic engineering. The path from a particle's surface to its therapeutic destination is no longer invisible.
Inside a living cell, a nanoparticle is a traveler without a map. It might find its target. It might be torn apart. It might be swept into a dead-end compartment by proteins that have no idea what it is. For years, researchers designing nanomedicines have faced a stubborn problem: they could not actually see what was happening once their engineered particles crossed the cell membrane.
The standard tools all had blindspots. Optical microscopy gave only a blurry, generalized picture of where particles ended up. Proteomics required destroying the cell entirely—lysing it—which scrambled the natural arrangement of proteins around the nanoparticle like shaking a snow globe. Proximity labeling, a more sophisticated technique, could map protein interactions in their native state, but it demanded genetic engineering: inserting foreign enzyme genes into cells to make the labeling work. That limitation meant the method could not be easily applied across different cell types and systems.
A team led by Liu Yuan and Jing Ji at the Hangzhou Institute of Medicine, working with Dai Yunlu at the University of Macau, has now sidestepped that entire problem. They developed what they call nanozyme proximity labeling—a method that requires no genetic modification at all. The key was to use iron oxide nanoparticles that already possess an enzyme-like activity. When exposed to hydrogen peroxide, these particles act like tiny chemical scissors, covalently tagging any proteins within arm's reach. The labeling happens in about a minute, in living cells, without any genetic tinkering.
The researchers then isolated the tagged proteins and ran them through mass spectrometry to identify exactly which proteins had been near the nanoparticle. This gave them a high-resolution snapshot of the nanoparticle's immediate neighborhood—its interactome—captured in the cell's natural state. They published their findings in the Proceedings of the National Academy of Sciences.
What they discovered was striking. When they compared nanoparticles designed to target mitochondria against nanoparticles with no special targeting, the difference was unmistakable. The mitochondria-targeted particles showed a 1.5-fold enrichment of mitochondrial proteins in their immediate vicinity. They had also recruited intracellular trafficking proteins that acted like docking stations, anchoring them to the mitochondria. The untargeted particles, by contrast, were routed almost entirely toward lysosomes—the cell's garbage disposal system—where they would be degraded and eliminated.
This is not merely a technical achievement. It is a window into how surface chemistry shapes destiny. A nanoparticle's fate inside a cell is not random. It is written into the particle's design. By revealing exactly which proteins interact with a particle at each stage of its journey, this method allows researchers to see the consequences of their design choices in real time. They can now understand, with precision, how to modify a nanoparticle's surface to send it toward a therapeutic target instead of toward destruction. The strategy works without genetic engineering, which means it can be applied across diverse cell types, tissues, and disease models. For nanomedicine—a field built on the promise of delivering drugs exactly where they are needed—this is a tool that could accelerate the path from laboratory concept to working therapy.
Notable Quotes
The NPL strategy requires no genetic modification and can be applied to dissect nanomedicine-biological interfaces— Research team at Hangzhou Institute of Medicine and University of Macau
The Hearth Conversation Another angle on the story
Why does it matter that this method doesn't require genetic engineering? Couldn't researchers just engineer the cells if they needed to?
Genetic engineering works in a lab dish, but it's a sledgehammer. You're inserting foreign genes, changing the cell's behavior. Once you do that, you're no longer studying what actually happens in a real cell. This method watches the cell as it is.
So the iron oxide nanoparticles are doing the work that would normally require an engineered enzyme?
Exactly. Iron oxide already has peroxidase-like activity—it's a natural property of the material. Add hydrogen peroxide, and it becomes a labeling tool. No genetic modification needed.
What does the 1.5-fold enrichment of mitochondrial proteins actually tell you?
It tells you the particle is being recognized and held in place. The mitochondrial proteins are clustering around it, and trafficking proteins are helping dock it there. The surface design is working as intended.
And the untargeted particles—they just get destroyed?
Routed to lysosomes, yes. The cell sees them as foreign and disposes of them. That's actually useful information. It shows you what happens when you don't design the surface carefully.
Could this method reveal why some nanomedicines fail in the body?
That's the real promise. If you can see exactly where a particle goes and what proteins it encounters, you can redesign it to avoid the pathways that lead to failure. You're not guessing anymore.